SINOPHARM GROUP 1/5/O.N. (X2S1) — Free Cash Flow Generation Index
SINOPHARM GROUP 1/5/O.N. (X2S1) has a Free Cash Flow Generation Index of 0.89x as of December 2025. Free cash flow of €12.52 Billion represents 1% of operating cash flow (€14.14 Billion). See X2S1 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
SINOPHARM GROUP 1/5/O.N. Free Cash Flow Generation Index (2021–2025)
Historical FCF Generation Index trend for SINOPHARM GROUP 1/5/O.N. across 5 annual periods. Explore SINOPHARM GROUP 1/5/O.N. debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for SINOPHARM GROUP 1/5/O.N. (2021–2025)
Year-by-year Free Cash Flow Generation Index for SINOPHARM GROUP 1/5/O.N.. For the full company profile including market capitalisation, see SINOPHARM GROUP 1/5/O.N. stock valuation.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.89x | €12.52 Billion | €14.14 Billion | €1.62 Billion | ▲ +6.8% |
| 2024 | 0.83x | €9.58 Billion | €11.55 Billion | €1.97 Billion | ▼ -4.0% |
| 2023 | 0.86x | €14.84 Billion | €17.17 Billion | €2.34 Billion | ▼ -2.3% |
| 2022 | 0.88x | €18.55 Billion | €20.96 Billion | €2.42 Billion | ▲ +16.8% |
| 2021 | 0.76x | €7.05 Billion | €9.31 Billion | €2.26 Billion | — |